Whole blood coagulation and platelet activation in the athlete: A comparison of marathon, triathlon and long distance cycling

European Journal of Medical Research

Volumn 15, Issue 2, 2010, Pages 59-65

  Hanke, Alexander A ^a   Staib, A ^a   Gorlinger K ^b   Perrey, M ^a   Dirkmann, D ^b   Kienbaum, P ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; THROMBOCYTE CONCENTRATE; FIBRIN;

ADULT; ARTICLE; ATHLETE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CYCLING; ENDURANCE SPORT; FEMALE; FIBRIN POLYMERIZATION; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE COUNT; MALE; MARATHON RUNNER; NORMAL HUMAN; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY; TRIATHLON; BLOOD CLOTTING PARAMETERS; CONTROLLED STUDY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; MAXIMUM CLOT FIRMNESS; PROTEIN POLYMORPHISM; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

EID: 77949632468     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-15-2-59     Document Type: Article

References (43)

1. Chan KL, Davies RA, Chambers RJ. Coronary thrombosis and subsequent lysis after a marathon. J Am Coll Cardiol. 1984;4:1322-1325.
2. Disdier P, Harle, Swiader L, Gambarelli-Mouillac N, Weiller PJ. [Retinal vein occlusions in a marathon runner]. Presse Med. 1992;21:582.
3. Gaudard A, Varlet-Marie E, Monnier JF et al. Exercise-induced central retinal vein thrombosis: possible involvement of hemorheological disturbances. A case report. Clin Hemorheol Microcirc. 2002;27:115-122.
4. Scobie BA. Gastrointestinal emergencies with marathon-type running: omental infarction with pancreatitis and liver failure with portal vein thrombosis. N Z Med J. 1998;111:211-212.
5. Thompson GR. Grand rounds - Hammersmith Hospital. Hazards of running a marathon. BMJ. 1997;314:1023-1025.
6. Whitson BA, Nath DS, Knudtson JR, Shumway SJ. Cardiopulmonary bypass in revascularization and fluid management of exercise-induced acute myocardial infarction. J Card Surg. 2006;21:480-483.
7. Markov LN. [The syndrome of disseminated intravascular coagulation in marathon athletes]. Ter Arkh. 1989;61:90-92.
8. Arai M, Yorifuji H, Ikematsu S et al. Influences of strenuous exercise (triathlon) on blood coagulation and fibrinolytic system. Thromb Res. 1990;57:465-471.
9. Dimitriadou C, Dessypris A, Louizou C, Mandalaki T. Marathon run II: Effects on platelet aggregation. Thromb Haemost. 1977;37:451-455.
10. Hilberg T, Glaser D, Reckhart C, Prasa D, Sturzebecher J, Gabriel HH. Blood coagulation and fibrinolysis after long-duration treadmill exercise controlled by individual anaerobic threshold. Eur J Appl Physiol. 2003;90:639-642.
11. Hilberg T, Prasa D, Sturzebecher J, Glaser D, Schneider K, Gabriel HH. Blood coagulation and fibrinolysis after extreme short-term exercise. Thromb Res. 2003;109:271-277.
12. Mandalaki T, Dessypris A, Louizou C, Bossinakou I, Panayotopoulou C, Antonopoulou A. Marathon run I: effects on blood coagulation and fibrinolysis. Thromb Haemost. 1977;37:444-450.
13. Mandalaki T, Dessypris A, Louizou C, Panayotopoulou C, Dimitriadou C. Marathon Run III: effects on coagulation, fibrinolysis, platelet aggregation and serum cortisol levels. A 3-year study. Thromb Haemost. 1980;43:49-52.
14. Mockel M, Ulrich NV, Heller G, Jr. et al. Platelet activation through triathlon competition in ultra-endurance trained athletes: impact of thrombin and plasmin generation and catecholamine release. Int J Sports Med. 2001;22:337-343.
15. Prisco D, Paniccia R, Bandinelli B et al. Evaluation of clotting and fibrinolytic activation after protracted physical exercise. Thromb Res. 1998;89:73-78.
16. Rock G, Tittley P, Pipe A. Coagulation factor changes following endurance exercise. Clin J Sport Med. 1997;7:94-99.
17. Rocker L, Taenzer M, Drygas WK, Lill H, Heyduck B, Altenkirch HU. Effect of prolonged physical exercise on the fibrinolytic system. Eur J Appl Physiol Occup Physiol. 1990;60:478-481.
18. Siegel AJ, Stec JJ, Lipinska I et al. Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol. 2001;88:918-20, A9.
19. Smith JE, Garbutt G, Lopes P, Pedoe DT. Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department. Br J Sports Med. 2004;38:292-294.
20. Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost. 2006;4:411-416.
21. Sumann G, Fries D, Griesmacher A et al. Blood coagulation activation and fibrinolysis during a downhill marathon run. Blood Coagul Fibrinolysis. 2007;18:435-440.
22. Weiss C, Seitel G, Bartsch P. Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc. 1998;30:246-251.
23. Weiss C, Welsch B, Albert M et al. Coagulation and thrombomodulin in response to exercise of different type and duration. Med Sci Sports Exerc. 1998;30:1205-1210.
24. HARTERT H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr. 1948;26:577-583.
25. Grogan R. Run, Pheidippides, Run! The story of the Battle of Marathon. Br J Sports Med. 1981;15:186-189.
26. Kinsey TE. Pheidippides and the Marathon run. Br J Sports Med. 1981;15:285-286.
27. Maron BJ, Poliac LC, Roberts WO. Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol. 1996;28:428-431.
28. Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995;27:641-647.
29. Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med. 1984;311:874-877.
30. Tunstall Pedoe DS. Marathon cardiac deaths : the london experience. Sports Med. 2007;37:448-450.
31. Willich SN, Lewis M, Lowel H, Arntz HR, Schubert F, Schroder R. Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med. 1993;329:1684-1690.
32. van Loon BJ, Heere LP, Kluft C, Briet E, Dooijewaard G, Meinders AE. Fibrinolytic system during long-distance running in IDDM patients and in healthy subjects. Diabetes Care. 1992;15:991-996.
33. Holzheimer RG, Stautner-Bruckmann C. Calf pain in runners may be caused by venous insufficiency. Eur J Med Res. 2008;13:218-220.
34. Bartsch P, Welsch B, Albert M, Friedmann B, Levi M, Kruithof EK. Balanced activation of coagulation and fibrinolysis after a 2-h triathlon. Med Sci Sports Exerc. 1995;27:1465-1470.
35. Li N, He S, Blomback M, Hjemdahl P. Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin. Arterioscler Thromb Vasc Biol. 2007;27:407-413.
36. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, nett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg. 2005;100:1576-1583.
37. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482-2494.
38. McNicol A, Israels SJ. Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets. 2008;8:99-117.
39. Cerneca E, Simeone R, Bruno G, Gombacci A. Coagulation parameters in senior athletes practicing endurance sporting activity. J Sports Med Phys Fitness. 2005;45:576-579.
40. Davidson RJ. March or exertional haemoglobinuria. Semin Hematol. 1969;6:150-161.
41. Robinson Y, Cristancho E, Boning D. Intravascular hemolysis and mean red blood cell age in athletes. Med Sci Sports Exerc. 2006;38:480-483.
42. Spicer AJ. Studies on march haemoglobinuria. Br Med J. 1970;1:155-156.
43. Ferrari E, Morgan G. Travel as a risk factor for venous thromboembolic disease. Eur J Med Res. 2004;9:146-149.